Matiadis, D.; Mavroidi, B.; Panagiotopoulou, A.; Methenitis, C.; Pelecanou, M.; Sagnou, M.
(E)-(1-(4-Ethoxycarbonylphenyl)-5-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxystyryl)-2-pyrazoline: Synthesis, Characterization, DNA-Interaction, and Evaluation of Activity Against Drug-Resistant Cell Lines. Molbank 2020, 2020, M1114.
https://doi.org/10.3390/M1114
AMA Style
Matiadis D, Mavroidi B, Panagiotopoulou A, Methenitis C, Pelecanou M, Sagnou M.
(E)-(1-(4-Ethoxycarbonylphenyl)-5-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxystyryl)-2-pyrazoline: Synthesis, Characterization, DNA-Interaction, and Evaluation of Activity Against Drug-Resistant Cell Lines. Molbank. 2020; 2020(1):M1114.
https://doi.org/10.3390/M1114
Chicago/Turabian Style
Matiadis, Dimitris, Barbara Mavroidi, Angeliki Panagiotopoulou, Constantinos Methenitis, Maria Pelecanou, and Marina Sagnou.
2020. "(E)-(1-(4-Ethoxycarbonylphenyl)-5-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxystyryl)-2-pyrazoline: Synthesis, Characterization, DNA-Interaction, and Evaluation of Activity Against Drug-Resistant Cell Lines" Molbank 2020, no. 1: M1114.
https://doi.org/10.3390/M1114
APA Style
Matiadis, D., Mavroidi, B., Panagiotopoulou, A., Methenitis, C., Pelecanou, M., & Sagnou, M.
(2020). (E)-(1-(4-Ethoxycarbonylphenyl)-5-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxystyryl)-2-pyrazoline: Synthesis, Characterization, DNA-Interaction, and Evaluation of Activity Against Drug-Resistant Cell Lines. Molbank, 2020(1), M1114.
https://doi.org/10.3390/M1114